TreeFrog Therapeutics

TreeFrog Therapeutics

Recherche en biotechnologie

Pessac, Nouvelle-Aquitaine 17 721 abonnés

Cell Therapy for All

À propos

TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients. TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant microtissues with unprecedented scalability and cell quality. Bringing together over 70 biophysicists, cell biologists and bioproduction engineers, TreeFrog Therapeutics raised $82M over the past 3 years to advance its pipeline of stem cell-based therapies in the field of neurodegeneration, cardio-metabolic disorders, and immuno-oncology. In 2022, the company will open technological hubs in Boston, USA, and Kobe, Japan, to drive the adoption of C-Stem and initiate co-development partnerships with leading academic, biotech and industry players in the field of cell therapy.

Site web
https://treefrog.fr/
Secteur
Recherche en biotechnologie
Taille de l’entreprise
51-200 employés
Siège social
Pessac, Nouvelle-Aquitaine
Type
Société civile/Société commerciale/Autres types de sociétés
Fondée en
2018
Domaines
Cell Therapy, Stem Cell, Stem cell mass-production, Cell therapy cGMP manufacturing, biomimetic 3D cell culture et bioreactor stem cell cultivation

Lieux

Employés chez TreeFrog Therapeutics

Nouvelles

Pages similaires

Parcourir les offres d’emploi

Financement

TreeFrog Therapeutics 4 rounds en tout

Dernier round

Série B

75 593 557,00 $US

Voir plus d’informations sur Crunchbase